Unresolved issues with noninferiority pragmatic trials: Results of a literature survey
Clinical Trials · 2024
DOI: 10.1177/17407745231206371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials, 2024. Verfasst von Maria M Ciarleglio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA. Hauptthemen laut MEDLINE: Research Design. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Issues with specification of margins, adherence, and analytic population can potentially bias results toward the alternative in randomized noninferiority pragmatic trials. To investigate this potential for bias, we conducted a targeted search of the medical literature to examine how noninferiority pragmatic trials address these issues.
Methods
An Ovid MEDLINE database search was performed identifying publications in New England Journal of Medicine, Journal of the American Medical Association, Lancet, or British Medical Journal published between 2015 and 2021 that included the words “pragmatic” or “comparative effectiveness” and “noninferiority” or “non-inferiority.” Our search identified 14 potential trials, 12 meeting our inclusion criteria (11 individually randomized, 1 cluster-randomized).
Results
Eleven trials had results that met the criteria established for noninferiority. Noninferiority margins were prespecified for all trials; all but two trials provided justification of the margin. Most trials did some monitoring of treatment adherence. All trials conducted intent-to-treat or modified intent-to-treat analyses along with per-protocol analyses and these analyses reached similar conclusions. Only two trials included all randomized participants in the primary analysis, one used multiple imputation for missing data. The percentage excluded from primary analyses ranged from ∼2% to 30%. Reasons for exclusion included randomization in error, nonadherence, not receiving assigned treatment, death, withdrawal, lost to follow-up, and incomplete data.
Conclusion
Specification of margins, adherence, and analytic population require careful consideration to prevent bias toward the alternative in noninferiority pragmatic trials. Although separate guidance has been developed for noninferiority and pragmatic trials, it is not compatible with conducting a noninferiority pragmatic trial. Hence, these trials should probably not be done in their current format without developing new guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT, USA.
ORCID-Profile: Maria M Ciarleglio
Zitieren
APA
Ciarleglio, M. M., Li, J., & Peduzzi, P. (2024). Unresolved issues with noninferiority pragmatic trials: Results of a literature survey. Clinical Trials. https://doi.org/10.1177/17407745231206371
Vancouver
Ciarleglio MM, Li J, Peduzzi P. Unresolved issues with noninferiority pragmatic trials: Results of a literature survey. Clinical Trials. 2024. doi:10.1177/17407745231206371
BibTeX
@article{Ciarleglio2024,
author = {Ciarleglio, Maria M and Li, Jiaxuan and Peduzzi, Peter},
title = {Unresolved issues with noninferiority pragmatic trials: Results of a literature survey},
journal = {Clinical Trials},
year = {2024},
doi = {10.1177/17407745231206371}
}
EUVIMED